• About
  • Contact
  • Advertise
  • Privacy Policy
  • Terms Of Use
Sunday, June 15, 2025
No Result
View All Result
Converseer
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports
No Result
View All Result
Converseer
No Result
View All Result
Home News

NAFDAC bans multi-dose anti-malarial drug over safety concerns

by Editorial Team
4 March 2025
in News

Mojisola-Adeyeye

The National Agency for Food and Drug Administration and Control (NAFDAC) has announced an immediate ban on the registration and use of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.

The announcement, made in a public statement issued by the NAFDAC’s Director-General Mojisola Adeyeye on Monday, sent shockwaves through Nigeria’s pharmaceutical and healthcare sectors, as the banned medication has been a widely used treatment for malaria; a disease that remains one of the country’s deadliest health challenges.

At the heart of NAFDAC’s decision is a disturbing discovery: the drug becomes unstable after being mixed, gradually losing its effectiveness. This degradation, the agency warned, poses serious health risks, from worsening malaria symptoms and delayed treatment to life-threatening complications.

“When a medication loses its effectiveness, it can jeopardize patient safety and public health,” the agency stated.

Read Also: Nigerian govt seeks private sector’s collaboration to attract investment in LPG sector

The ban applies to all brands and versions of the drug, whether locally manufactured or imported. Effective immediately, NAFDAC will no longer process new applications, renewals, or variations for this product, halting its legal circulation in Nigeria.

To enforce the ban, NAFDAC has instructed its zonal directors and state coordinators to launch a nationwide surveillance operation aimed at removing the drug from shelves and distribution channels.

The agency also issued a stern warning to importers, distributors, retailers, and healthcare professionals to immediately stop the importation, sale, and use of the affected product, urging swift compliance to prevent further risks.

“The public is also encouraged to report any sightings of these items or incidents involving substandard or falsified medicines to the nearest NAFDAC office,” the statement added.

Healthcare providers and consumers were advised to report any adverse effects linked to the drug through NAFDAC’s e-reporting platforms, accessible on the agency’s website.

Taking the matter beyond Nigeria’s borders, NAFDAC announced plans to notify the World Health Organization’s Global Surveillance and Monitoring System about the ban. This step, the agency said, ensures international awareness and compliance, preventing the distribution of these compromised medications in other regions.

Source: Ripples

Tags: General News

Related News

Trump to impose visa ban on Nigerians, 35 other countries

Trump to impose visa ban on Nigerians, 35 other countries

15 June 2025
Dr Alalibo assumes office as new Cross River INEC REC

Dr Alalibo assumes office as new Cross River INEC REC

14 June 2025
Birth Registration: C'River NPC partners First Lady office

Birth Registration: C’River NPC partners First Lady office

12 June 2025
Climate change hits women farmers hard in Cross River

Climate change hits women farmers hard in Cross River

12 June 2025

Latest News

Trump to impose visa ban on Nigerians, 35 other countries

Calabar residents scamper for petrol from crashed tanker

Dr Alalibo assumes office as new Cross River INEC REC

Mali to add 3,000 to security amid push for sovereignty

Zero-tariff: Nigeria gains access to Chinese market

CRSG rewards Best WAEC Student with N200,000

About Us

Converseer is an online newspaper that delivers impartial, comprehensive news coverage on politics, business, and education, among other topics. Our goal is to bridge the information gap and promote progress across various sectors of society.

Social Media

  • Facebook
  • WhatsApp
  • X (Twitter)
  • YouTube

Coverage

  • Africa
  • Americas
  • Asia
  • Europe
  • Middle East

Topics

  • Special Reports
  • Fact Check
  • Feature
  • Opinion
  • History
  • About
  • Contact
  • Advertise
  • Privacy Policy
  • Terms Of Use

© 2025 Converseer - All Rights Reserved. Paradise Media Venture.

No Result
View All Result
  • Home
  • News
    • General News
    • Education
    • Business
    • Security
    • Entertainment
    • Lifestyle
    • Tourism
  • Politics
  • Metro
  • Jobs
  • Sports
  • Health
  • Tech
  • More
    • Science & Nature
    • Agriculture
    • Opinion
    • Feature
    • Fact Check
    • History
    • Profile & Biography
    • Special Reports

© 2025 Converseer - All Rights Reserved. Paradise Media Venture.